A New Definition of Pharmaceutical Quality: Assembly of a Risk Simulation Platform to Investigate the Impact of Manufacturing/ Product Variabcpility on Clinical Performance
- 1 December 2010
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 99 (12) , 5046-5059
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Risk-based Quality by Design (QbD): A Taguchi Perspective on the Assessment of Product Quality, and the Quantitative Linkage of Drug Product Parameters and Clinical PerformanceJournal of Pharmaceutical Innovation, 2008
- The Financial Returns on Investments in Process Analytical Technology and Lean Manufacturing: Benchmarks and Case StudyJournal of Pharmaceutical Innovation, 2007
- The use of Monte Carlo simulations to study the effect of poor compliance on the steady state concentrations of valproic acid following administration of enteric‐coated and extended release divalproex sodium formulationsBiopharmaceutics & Drug Disposition, 2005
- A Brief Introduction to Monte Carlo SimulationClinical Pharmacokinetics, 2001
- Controlled-Release Hydrophilic Tablets for Individualized Theophylline TherapyDrug Development and Industrial Pharmacy, 1999
- Release and Absorption Characteristics of Novel Theophylline Sustained-Release Formulations: In Vitro-in Vivo CorrelationPharmaceutical Research, 1990
- Estimation of Theophylline Clearance During Intravenous Aminophylline InfusionsJournal of Pharmaceutical Sciences, 1985
- Theophylline QID, TID, BID and Now QD?Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1984
- Factors affecting theophylline clearances: Age, tobacco, marijuana, cirrhosis, congestive heart failure, obesity, oral contraceptives, benzodiazepines, barbiturates, and ethanolJournal of Pharmaceutical Sciences, 1979
- THEOPHYLLINE DISPOSITION IN ACUTELY ILL HOSPITALIZED-PATIENTS - EFFECT OF SMOKING, HEART-FAILURE, SEVERE AIRWAY-OBSTRUCTION, AND PNEUMONIA1978